Latest stories on ABCL
AbCellera and Vertex launch autoimmune T-cell engager partnership
TipRanks56 · neutralproduct/pr
AbCellera Biologics Inc. (ABCL) files 8-K
SEC 8-K50 · neutralgeneral
AbCellera inks drug discovery deal with Vertex Pharma
Seeking Alpha67 · bullishm&a
AbCellera Secures $28 Million Vertex Deal to Advance T-Cell Engager Platform for Autoimmune Therapies
July 29, 2026
MarketChameleon73 · bullishm&a
Cantor Fitzgerald reiterates Overweight on AbCellera stock at $11
Investing.com Analyst Ratings61 · neutralanalyst
3 Under-$10 Stocks with Strong Upside to Watch This Week, According to Analysts
TipRanks57 · neutralanalyst
AbCellera Sets Q2 2026 Earnings Date—Clinical-Stage Pipeline Remains in Focus
July 8, 2026
MarketChameleon50 · neutralearnings
AbCellera to Report Second Quarter 2026 Financial Results on August 5, 2026 | ABCL Stock News
StockTitan50 · neutralearnings
AbCellera Biologics Adds Independent Director to Board
TipRanks55 · neutralgeneral
AbCellera Biologics Inc. (ABCL) files 8-K
SEC 8-K50 · neutralgeneral
AbCellera Appoints Dr. Lynn Seely to its Board of Directors | ABCL Stock News
StockTitan56 · neutralgeneral
Is AbCellera Biologics (ABCL) One of the Best Stocks with Biggest Upside?
Yahoo Top66 · bullishanalyst
Jazz Pharmaceuticals and AbCellera Biologics Inc. (ABCL) Announce Collaboration
Yahoo Finance63 · neutralgeneral
AbCellera, Jazz Partner on Next-Generation Cancer Antibodies
TipRanks63 · neutralproduct/pr
AbCellera Biologics Inc. (ABCL) files 8-K
SEC 8-K50 · neutralgeneral
Jazz Pharmaceuticals and AbCellera Partner on Antibody Programs for Solid Tumors
Yahoo Finance63 · neutralproduct/pr
Jazz, AbCellera in deal to develop T-cell engaging multispecific antibodies
Seeking Alpha67 · bullishm&a
AbCellera Secures $56 Million Jazz Pharmaceuticals Deal to Develop Next-Gen T-Cell Antibody Therapies
MarketChameleon73 · bullishm&a
AbCellera: An AI-Era Antibody Platform Trading For Little More Than Its Cash
Seeking Alpha58 · neutralgeneral
AbCellera Biologics Inc. (ABCL) files 8-K
SEC 8-K50 · neutralgeneral
AbCellera: Q3 Hot Flashes Data Drop Aside, This Stock Is A Difficult Sell
Seeking Alpha53 · neutralgeneral
AbCellera Biologics Inc. (ABCL) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Seeking Alpha55 · neutralgeneral
AbCellera Appoints Dr. Victor Sandor to its Board of Directors | ABCL Stock News
StockTitan56 · neutralgeneral